MedTrace Logo

International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms

NCT05334680 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2023-01-19

No results posted yet for this study

Summary

1. Deploy wearable COVID sensor to collect high resolution physiological data (temperature, cardiac, respiratory and physical activity) from COVID positive patients.
2. Use collected data to train algorithm for assessing the risk of individuals presenting with symptoms suggestive of COVID-19.

Conditions

Interventions

DEVICE

ANNE Sensor

The data collected from this sensor contains a wide range of core and novel respiratory digital biomarkers as a home-based early identification system. The core measurements include: heart rate, heart rate variability, temperature, physical activity (including sleep quality) and respiratory rate. The novel respiratory digital biomarkers include: respiratory cadence (expiration / inspiration time), coughing, swallowing, throat clearing, and talk time.

Sponsors & Collaborators

  • United States - India Science and Technology Endowment Fund

    collaborator UNKNOWN

  • Northwestern University

    collaborator OTHER

  • Induss Hospitals

    collaborator UNKNOWN

  • Bionic Yantra

    collaborator UNKNOWN

  • Clinfinite Solutions

    collaborator NETWORK

  • Indian Institute of Technology Kharagpur

    collaborator UNKNOWN

  • Arun Jayaraman, PT, PhD

    lead OTHER

Principal Investigators

  • Arun Jayaraman, PT, PhD · Shirley Ryan AbilityLab

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2023-03-08
Completion
2023-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05334680 on ClinicalTrials.gov